125 related articles for article (PubMed ID: 36652730)
1. Machine learning-based models for genomic predicting neoadjuvant chemotherapeutic sensitivity in cervical cancer.
Guo L; Wang W; Xie X; Wang S; Zhang Y
Biomed Pharmacother; 2023 Mar; 159():114256. PubMed ID: 36652730
[TBL] [Abstract][Full Text] [Related]
2. Machine learning for genetic prediction of chemotherapy toxicity in cervical cancer.
Guo L; Wang W; Xie X; Wang S; Zhang Y
Biomed Pharmacother; 2023 May; 161():114518. PubMed ID: 36906972
[TBL] [Abstract][Full Text] [Related]
3. Genetic variations in the PI3K/AKT pathway predict platinum-based neoadjuvant chemotherapeutic sensitivity in squamous cervical cancer.
Guo L; Wu H; Zhu J; Zhang C; Ma J; Lan J; Xie X
Life Sci; 2015 Dec; 143():217-24. PubMed ID: 26585822
[TBL] [Abstract][Full Text] [Related]
4. Decreasing expression of HIF-1α, VEGF-A, and Ki67 with efficacy of neoadjuvant therapy in locally advanced cervical cancer.
Zhao K; Hu M; Yang R; Liu J; Zeng P; Zhao T
Medicine (Baltimore); 2023 May; 102(20):e33820. PubMed ID: 37335690
[TBL] [Abstract][Full Text] [Related]
5. The Role of 2D/3D Ultrasound to Assess the Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer.
Perniola G; Tomao F; Graziano M; Palaia I; Fischetti M; Lecce F; Casorelli A; Di Donato V; Giancotti A; Battaglia FA; Muzii L; Benedetti Panici P
Oncology; 2020; 98(11):807-813. PubMed ID: 32892198
[TBL] [Abstract][Full Text] [Related]
6. Analysis of short-term efficacy as defined by RECIST and pathological response of neoadjuvant chemotherapy comprised paclitaxel and cisplatin followed by radical surgery in patients with locally advanced cervical cancer: A prospective observational study.
He Y; Zhao Q; Geng YN; Yang SL; Li XM; Finas D; Yin CH; Wu YM
Medicine (Baltimore); 2018 Jun; 97(22):e10913. PubMed ID: 29851821
[TBL] [Abstract][Full Text] [Related]
7. Basic T1 Perfusion magnetic resonance imaging evaluation of the therapeutic effect of neoadjuvant chemotherapy in locally advanced cervical cancer.
Fu C; Feng X; Bian D; Du W; Wang X; Zhao Y
Int J Gynecol Cancer; 2013 Sep; 23(7):1270-8. PubMed ID: 23970155
[TBL] [Abstract][Full Text] [Related]
8. The genetic variants in the PTEN/PI3K/AKT pathway predict susceptibility and CE(A)F chemotherapy response to breast cancer and clinical outcomes.
Li X; Zhang R; Liu Z; Li S; Xu H
Oncotarget; 2017 Mar; 8(12):20252-20265. PubMed ID: 28423632
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict platinum-based chemotherapy response of advanced non-small cell lung cancers in a Chinese population.
Xu JL; Wang ZW; Hu LM; Yin ZQ; Huang MD; Hu ZB; Shen HB; Shu YQ
Asian Pac J Cancer Prev; 2012; 13(5):2157-62. PubMed ID: 22901187
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Clinical Benefits of Neoadjuvant Chemotherapy in Women With Locally Advanced Cervical Cancer: Validity of Pathological Response as Surrogate Endpoint of Survival.
Buda A; Lissoni AA; Floriani I; Biagioli E; Gerardi C; Bonazzi C; Chiari S; Locatelli L; Dell'Anna T; Signorelli M; Mangioni C; Milani R
Int J Gynecol Cancer; 2015 Oct; 25(8):1468-75. PubMed ID: 26222484
[TBL] [Abstract][Full Text] [Related]
11. The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer.
Yin M; Zhang H; Li H; Li X; Liu Y; Chen X; Lou G; Li K
J Surg Oncol; 2012 Feb; 105(2):206-11. PubMed ID: 21815150
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous changes of magnetic resonance diffusion-weighted imaging and pathological microstructure in locally advanced cervical cancer caused by neoadjuvant chemotherapy.
Fu C; Feng X; Bian D; Zhao Y; Fang X; Du W; Wang L; Wang X
J Magn Reson Imaging; 2015 Aug; 42(2):427-35. PubMed ID: 25328994
[TBL] [Abstract][Full Text] [Related]
13. The value of diffusion-weighted magnetic resonance imaging in assessing the response of locally advanced cervical cancer to neoadjuvant chemotherapy.
Fu C; Bian D; Liu F; Feng X; Du W; Wang X
Int J Gynecol Cancer; 2012 Jul; 22(6):1037-43. PubMed ID: 22683941
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Radical Surgery Alone in Locally Advanced Cervical Cancer Patients.
Gong L; Zhang JW; Yin RT; Wang P; Liu H; Zheng Y; Lou JY; Peng ZL
Int J Gynecol Cancer; 2016 May; 26(4):722-8. PubMed ID: 26905330
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of robotic radical hysterectomy after neoadjuvant chemotherapy in women with locally advanced cervical cancer.
Minig L; Zanagnolo V; Cárdenas-Rebollo JM; Colombo N; Maggioni A
Eur J Surg Oncol; 2016 Sep; 42(9):1372-7. PubMed ID: 27247200
[TBL] [Abstract][Full Text] [Related]
16. Rs2686344 and serum squamous cell carcinoma antigen could predict clinical efficacy of neoadjuvant chemotherapy for cervical cancer.
Li T; Huang H; Hu Y; Chen H; Li R; Lu H; Yan L; Chen Y; Zhang C; Zhang Q; Li X
Curr Probl Cancer; 2021 Dec; 45(6):100755. PubMed ID: 33902928
[TBL] [Abstract][Full Text] [Related]
17. Association Between HIF-1 Alpha Gene Polymorphisms and Response in Patients Undergoing Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer.
Chen Q; Tian WJ; Huang ML; Liu CH; Yao TT; Guan MM
Med Sci Monit; 2016 Sep; 22():3140-6. PubMed ID: 27593081
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy for locally advanced cervical cancer reduces surgical risks and lymph-vascular space involvement.
Wang Y; Wang G; Wei LH; Huang LH; Wang JL; Wang SJ; Li XP; Shen DH; Bao DM; Gao J
Chin J Cancer; 2011 Sep; 30(9):645-54. PubMed ID: 21880186
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy followed by radical surgery reduces radiation therapy in patients with stage IB2 to IIA2 cervical cancer.
Huang Y; Chen L; Cai J; Yang L; Sun S; Zhao J; Xiong Z; Wang Z
World J Surg Oncol; 2022 Aug; 20(1):264. PubMed ID: 35996118
[TBL] [Abstract][Full Text] [Related]
20. Total Mesometrial Resection With (Neo)Adjuvant Chemotherapy in Locally Advanced Cervical Cancer: A Tumor Response Score.
Kiesel M; Sauer S; Löb S; Herbert SL; Wöckel A; Wulff C
Anticancer Res; 2021 Jul; 41(7):3543-3560. PubMed ID: 34230150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
